Mc Guire Investment Group, LLC Altimmune, Inc. Transaction History

Mc Guire Investment Group, LLC

  • $704 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 16, 2021
SELL
$9.85 - $16.46 $1.91 Million - $3.19 Million
-193,551 Closed
0 $0
Q1 2021

Apr 20, 2021
BUY
$12.71 - $24.31 $2.12 Million - $4.05 Million
166,646 Added 619.39%
193,551 $2.74 Million
Q4 2020

Jan 13, 2021
BUY
$7.84 - $14.22 $210,935 - $382,589
26,905 New
26,905 $303,000

Others Institutions Holding ALT

# of Institutions
186
Shares Held
39.3M
Call Options Held
913K
Put Options Held
743K
View Full List

About Altimmune, Inc.

ALT Quotes by TradingView
  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $428M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Mc Guire Investment Group, LLC Portfolio

Follow Mc Guire Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Guire Investment Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email